Development and Application Value
Assessment of a Method for Measuring the Quality of Volume Calibration Syringes

doi:10.12114/j.issn.1007-9572.2021.01.037

Abstract

Abstract: Background

Pulmonary examination is a measurement technique in medicine, and the quality of examination equipment is a key factor associated with the accuracy of examination results. Guidelines for mechanical lung function measurements have proposed that the spirometer should be calibrated each time it is used by the calibration cylinder for quality control, so the accuracy of the calibration cylinder will directly associate with that of the spirometer. However, there are no reports on the accuracy, and eligible standards, as well as calibration procedure regarding spirometer calibration cylinders measured by relevant research institutions (including calibration cylinder manufacturers) .

Objective

To develop a method, and use it to measure the performance of volume calibration cylinders commonly applied in China to assess its application value.

Methods

According to the standards for 3 L calibration syringe proposed in the Standardization of Spirometry 2019 Update issued by the American Thoracic Society (ATS) /European Respiratory Society (ERS) , the 1180 cylinder verifier (produced by Hans Rudolph, inc.) was used in the leak test and volume accuracy test for measuring the performance of five brands of imported/domestic calibration cylinders (Two were produced by Germany's CareFusion, and Vyaire, respectively, one by MGC Diagnostics, USA, and the other two by China's Zhejiang U-Breath, and Ningbo Wendi Medical Instrument CO, LTD, respectively) .

Results

Of the five brands of calibration cylinders, 4/5 had less than 1 ml/min in the pressure attenuation leakage test, 4/5 had a volume error of less than 0.5% of the target volume, with an error range of less than 0.05% of the target volume, 3/5 passed both tests.

Conclusion

In this study, the method of directly measuring the change of gas volume of volume calibration cylinder is used for quality detection. The method is simple and feasible. It is recommended that the calibration cylinder should be regularly checked for assuring the accuracy.

Key words: Lung diseases, Respiratory function tests, Respiratory tract diseases, Volume calibration cylinder, Calibration cylinder verifier, Quality control, Leak test

摘要： 背景

肺功能检查是一种医学计量技术，检查设备的质量是影响检查结果的关键环节之一。国内外肺功能检查指南均提出在进行质量控制标准时每次启动肺量计均需经容量定标筒校准，容量定标筒的准确性直接影响肺量计计算指标数值的准确性，但国内外所有研究机构（包括容量定标筒生产厂家）从未对容量定标筒自身的准确性进行校准验证，也无相关操作流程和通过标准。

目的

对国内临床常用肺功能仪容量定标筒进行检测技术性能分析，了解我国常用容量定标筒的性能情况，探索该方法在容量定标筒验证中的应用价值。

方法

2021年7月，根据美国胸科学会（ATS）/欧洲呼吸协会（ERS）在2019年发布的肺量计检查指南更新版中提出的3 L容量定标筒校准的要求，采用美国Hans Rudolph公司1180型容量定标筒验证器对5个品牌容量定标筒（德国CareFusion、德国Vyaire、美国MGC diangostics、中国浙江U-Breath、中国浙江宁波文迪）进行压力泄露测试和容积准确性测试。

结果

5个品牌容量定标筒的压力泄露测试结果小于1 ml/min的占4/5；容积误差小于目标容积的0.5%且误差重复性小于目标容积的0.05%占4/5，两种测试均通过的占3/5。

结论

本研究使用直接测量容量定标筒气体容积变化的方法进行质量检测，方法简便可行，建议定期对容量定标筒进行质量校准。

关键词: 肺疾病, 呼吸功能试验, 呼吸道疾病, 容量定标筒, 容量定标筒验证器, 质量控制, 泄漏测试

CLC Number:

R563R443.6

WU Zhongping, HUANG Ruibo, ZHENG Jinping, GAO Yi.

Development and Application Value Assessment of a Method for Measuring the Quality of Volume Calibration Syringes [J]. Chinese General Practice, 2022, 25(02): 149-152.

吴仲平,黄锐波,郑劲平等. 肺功能仪容量定标筒的质量检测方法的建立及其应用价值对比研究[J]. 中国全科医学, 2022, 25(02): 149-152. DOI: 10.12114/j.issn.1007-9572.2021.01.037.

Figures/Tables 2

References 9

[1]	GRAHAM B L，STEENBRUGGEN I，MILLER M R，et al. Standardization of spirometry 2019 update. an official American thoracic society and European respiratory society technical statement[J]. Am J Respir Crit Care Med，2019，200（8）：e70-88. DOI：10.1164/rccm.201908-1590ST.
[2]	中华医学会呼吸病学分会肺功能专业组. 肺功能检查指南（第二部分）——肺量计检查[J]. 中华结核和呼吸杂志，2014，37（7）：481-486. DOI：10.3760/cma.j.issn.1001-0939.2014.07.001.
[3]	MCCORMACK M C，SHADE D，WISE R A. Spirometer calibration checks：is 3.5% good enough?[J]. Chest，2007，131（5）：1486-1493. DOI：10.1378/chest.06-1522.
[4]	GRAHAM B L.，BRUSASCO V，BURGOS F，et al. 2017 ERS/ATS standards for single-breath carbon monoxide uptake in the lung[J]. Eur Respir J，2017，49（1）：16E0016. DOI：10.1183/13993003.E0016-2016.
[5]	张冬莹，高怡，简文华，等. 肺功能检查技术在基层医疗卫生机构推广可行性及建议[J]. 中国全科医学，2020，23（29）：3638-3643. DOI：10.12114/j.issn.1007-9572.2020.00.463.
[6]	QUANJER P H，TAMMELING G J，COTES J E，et al. Lung volumes and forced ventilatory flows[J]. Eur Respir J，1993，6（）：5-40. DOI：10.1183/09041950.005s1693.
[7]	American Thoracic Society. Standardization of Spirometry，1994 Update[J]. Am J Respir Crit Care Med，1995，152（3）：1107-1136.
[8]	MILLER M R. Standardisation of spirometry[J]. Eur Respir J，2005，26（2）：319-338. DOI：10.1183/09031936.05.00034805.
[9]	MADSEN F. Validation of spirometer calibration syringes[J]. Scand J Clin Lab Invest，2012，72（8）：608-613. DOI：10.3109/00365513.2012.723739.

评价指标		品牌1	品牌2	品牌3	品牌4	品牌5	总体通过率（%）
压力泄露测试
	目标容积（ml）	3 000.000	3 000.000	1 000.000	3 000.000	3 000.000
	目标泄露（ml/min）	0.000	0.000	0.000	0.000	0.000
	实际平均泄露（ml/min）	0.190	0.450	0.100	2.470	0.840	80.00
	泄露平均误差值（ml/min）	0.190	0.450	0.100	2.470	0.840	80.00
	是否通过（Y/N）	Y	Y	Y	N	Y	80.00
容积准确性测试
	目标容积（ml）	3 000.000	3 000.000	1 000.000	3 000.000	3 000.000
	容积平均测量值（ml）	2 994.674	3 003.005	992.219	2 990.861	3 001.187	80.00
	容积平均误差范围（ml）	0.383	0.537	0.520	0.795	0.367	80.00
	容积平均误差值（ml）	-5.326	3.005	-7.781	-9.139	1.187	80.00
	是否通过（Y/N）	Y	Y	N	Y	Y	80.00
两项测试
	是否通过（Y/N）	Y	Y	N	N	Y	60.00

评价指标		品牌1	品牌2	品牌3	品牌4	品牌5	总体通过率（%）
压力泄露测试
	目标容积（ml）	3 000.000	3 000.000	1 000.000	3 000.000	3 000.000
	目标泄露（ml/min）	0.000	0.000	0.000	0.000	0.000
	实际平均泄露（ml/min）	0.190	0.450	0.100	2.470	0.840	80.00
	泄露平均误差值（ml/min）	0.190	0.450	0.100	2.470	0.840	80.00
	是否通过（Y/N）	Y	Y	Y	N	Y	80.00
容积准确性测试
	目标容积（ml）	3 000.000	3 000.000	1 000.000	3 000.000	3 000.000
	容积平均测量值（ml）	2 994.674	3 003.005	992.219	2 990.861	3 001.187	80.00
	容积平均误差范围（ml）	0.383	0.537	0.520	0.795	0.367	80.00
	容积平均误差值（ml）	-5.326	3.005	-7.781	-9.139	1.187	80.00
	是否通过（Y/N）	Y	Y	N	Y	Y	80.00
两项测试
	是否通过（Y/N）	Y	Y	N	N	Y	60.00

[1]	ZHAO Xuedan, AI Yue, JIN Guoen, JIA Guoqiang. The New Research Progress of Non-infectious Lung Diseases in High Altitude Areas [J]. Chinese General Practice, 2026, 29(14): 1931-1938.
[2]	YAO Shihua, HUANG Ruibo, FU Tuping, WU Zhongping, CHEN Shubing, XIE Yanqing, SHEN Beilan, ZHONG Liping, AN Jiaying, WANG Xudong, LIU Wenting, YU Xinxin, ZHENG Jinping, GAO Yi. Evaluation of the Clinical Application Value of Domestic New-type MeHow MeAir 9000 in Diffusing Capacity of the Lung Tests for Chronic Respiratory Diseases [J]. Chinese General Practice, 2025, 28(34): 4371-4377.
[3]	WU Zhongping, ZHENG Jingping, GAO Yi, CHEN Xiaoliang. Investigation and Analysis of the Current Status of Bronchial Provocation Testing in Guangdong Province [J]. Chinese General Practice, 2025, 28(33): 4166-4171.
[4]	The General Practice Branch of the Chinese Medical Doctor Association. Implementation Recommendations for Quality Management and Control in General Practice at Primary Healthcare Institutions (2025 Edition) [J]. Chinese General Practice, 2025, 28(28): 3473-3482.
[5]	TAN Huihui, MAO Wei, YANG Zihan. Research Progress of Annexin A1 in Respiratory Diseases [J]. Chinese General Practice, 2025, 28(13): 1668-1673.
[6]	XU Linhui, LI Pengfei, WU Miaomiao, KANG Lihua, JI Min, YU Ying, GUAN Huaijin. The Roles of Deubiquitination in Age-related Diseases [J]. Chinese General Practice, 2025, 28(09): 1143-1155.
[7]	YANG Jianuo, WANG Guanli, YANG Jiafu, HE Jiahao, CHEN Shumin, SHEN Yi, LI Juan, REN Ni, LIU Chunli, DENG Fangge. New Progress in the Application of Infrared Thermal Imaging in Pulmonary Diseases [J]. Chinese General Practice, 2025, 28(08): 1012-1016.
[8]	ZHANG Dongying, YE Peitao, LI Qiasheng, JIAN Wenhua, LIANG Zhenyu, ZHENG Jinping. Study of Techniques and Methods for Building a Database of Lung Auscultation Sounds [J]. Chinese General Practice, 2024, 27(36): 4598-4608.
[9]	LI Chunyang, WANG Jiajia, WEI Mengyu, LI Jiansheng. Research Status of Patient-reported Outcome Measurements for Acute Exacerbation of Chronic Obstructive Pulmonary Disease [J]. Chinese General Practice, 2024, 27(31): 3896-3904.
[10]	YANG Can, LI Ning, LI Xuefei, ZHAO Li, XU Hao, SHI Qi, WANG Yongjun, LIANG Qianqian. Efficacy of Zang Bi Formula in Treating Arthritis and Its Pulmonary Complications in Rheumatoid Arthritis Interstitial Lung Disease Mice [J]. Chinese General Practice, 2024, 27(24): 3015-3022.
[11]	SU Ziwei, MA Yan, ZHOU Yanzhang, ZHOU Zhiliang. Advances in Traditional Chinese Medicine Regulating Mitochondrial Quality Control in the Treatment of Ischemic Stroke [J]. Chinese General Practice, 2024, 27(24): 3023-3030.
[12]	ZHAO Zezhou, WANG Jieping, DU Xueping, WU Wei, YAN Wei, LI Qian, GUAN Yajie. Study on the Status of Consultations in General Medicine Departments in Tertiary Care Hospitals [J]. Chinese General Practice, 2024, 27(19): 2319-2323.
[13]	YUAN Quan, LU Haiying, WANG Yi, LIU Yunxiao, YU Jiaqin, TIAN Fengzhao, LI Yao. Telemedicine Management in Stabilized Respiratory Rehabilitation of Elderly Patients with Moderate-to-severe Chronic Obstructive Pulmonary Disease: a Randomized Controlled Trial [J]. Chinese General Practice, 2024, 27(06): 711-716.
[14]	PENG Yongyi, WU Zhongping, HUANG Jinhai, LIN Junfeng, CHEN Shubing, ZHENG Jinping, GAO Yi. Discussion on the Quality Control Test Method for a New Inhalation Drug Quantitative Assessment Instrument [J]. Chinese General Practice, 2024, 27(06): 758-764.
[15]	LIANG Xuan, NA Feiyang, QIN Mengyao, YANG Hui, GUO Li, GUO Qi, REN Lei, CHEN De, LIU Donghai, ZHANG Rongfang. Clinical Characteristics and Influencing Factors of Bronchial Asthma Combined with Obstructive Sleep Apnea-hypopnea Syndrome in Children [J]. Chinese General Practice, 2023, 26(33): 4225-4230.